NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
18.49
-0.06 (-0.32%)
Apr 25, 2025, 4:00 PM EDT - Market closed
NovoCure Employees
NovoCure had 1,488 employees as of December 31, 2024. The number of employees increased by 35 or 2.41% compared to the previous year.
Employees
1,488
Change (1Y)
35
Growth (1Y)
2.41%
Revenue / Employee
$417,817
Profits / Employee
-$110,340
Market Cap
2.06B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
NVCR News
- 3 days ago - NovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025 - Benzinga
- 3 days ago - NovoCure Limited (NVCR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Novocure Reports First Quarter 2025 Financial Results - Business Wire
- 4 days ago - Novocure to Present Results from the Phase 3 PANOVA-3 Clinical Trial of its Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer as a Late-Breaking Oral Presentation at the 2025 ASCO Annual Meeting - Business Wire
- 5 days ago - Novocure's Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer - Business Wire
- 26 days ago - Novocure to Report First Quarter 2025 Financial Results - Business Wire
- 7 weeks ago - Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference - Business Wire
- 2 months ago - NovoCure Q4 2024 Earnings: Strong And Growing Pipeline - Seeking Alpha